To evaluate if DEF8 protein levels are correlated with increased mRNA expression in AD tissues, we performed immunostaining of DEF8 in postmortem frontal cortex samples from AD patients and compared it to samples from control (healthy) individuals. Here, DEF8 is linked to Alzheimer disease.